Breaking News

Worldwide Clinical Trials Selects BioClinica's OnPoint CTMS

By Kristin Brooks | March 6, 2014

Aims to improve efficiencies in data and work flow with reduced operational expenses

Worldwide Clinical Trials, Inc. has selected BioClinica's OnPoint CTMS (clinical trial management system) to support international studies for all phases of drug development in various therapeutic areas. With the implementation of OnPoint CTMS, Worldwide Clinical anticipates improved efficiencies in data flow and workflow with cost-savings in time, labor, and operational expenses.

OnPoint will provide role-based access to users globally, including clinical research associates, monitors, study managers, operations and site personnel, as well as executives and sponsor users. OnPoint manages a clinical trial from the start and maintains role-based access control from study design through close-out and FDA submission. The CTMS includes tools to plan, start, conduct, and manage studies and complete monitoring and regulatory compliance activities.

"We believe well-integrated technologies enhance clinical development and the decision to replace our existing trial management system with BioClinica's OnPoint reflects this. It also gives us broader functionality along with predictable pricing," said Tom Wardle, chief operating officer, Worldwide Clinical Trials. "After conducting an extensive evaluation of industry-leading CTMS providers, we selected OnPoint for its flexibility, scalability, and superior technical support." BioClinica's Office-smart CTMS utilizes Microsoft SharePoint to foster collaboration and connectivity in multi-site study environments.

BioClinica's Peter Benton, president of eClinical Solutions, said, "With the large amount of data generated across so many trials and individual study activities, it can be hard to control and manage it all. Because OnPoint handles studies of any size and complexity securely and compliantly, we're seeing wide adoption by major players like Worldwide Clinical Trials. Everyone who sees our MVR wants it." BioClinica's innovative Monitor Visit Report (MVR)replaces conventional manual transcription with an electronic visit report that can be securely accessed and updated anytime and anywhere whether online or offline.

Related Compliance:

  • CROs and Today’s  R&D Landscape

    CROs and Today’s R&D Landscape

    Kristin Brooks, Associate Editor, Contract Pharma||November 9, 2016
    John Lewis of ACRO discusses opportunities, challenges, and the future CRO

  • The Human Parts of Mouse Models

    The Human Parts of Mouse Models

    Julia Schueler, Head of in vivo Operations, Oncotest, a Charles River company ||October 11, 2016
    The PDX model system has come back into focus

  • Choosing Oral Formulations for First-in-man Clinical Trials

    Choosing Oral Formulations for First-in-man Clinical Trials

    Jon Sutch, Senior Manager of Formulation Development, Patheon||October 11, 2016
    Early formulations should be simple, but selecting a simple formulation isn’t as easy as it seems